Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma

Modern Pathology

Volumn 21, Issue 11, 2008, Pages 1303-1310

  Wang, Wei Lien ^a   Mayordomo, Empar ^b   Czerniak, Bogdan A ^a   Abruzzo, Lynne V ^a   Cin, Paola Dal ^c   Araujo, Dejka M ^a   Lev, Dina C ^a   López Terrada, Dolores ^b   Lazar, Alexander J F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

EWSR1; Extraskeletal myxoid chondrosarcoma; Fluorescence in situ hybridization; NR4A3; t(9; 22)

Indexed keywords

DNA BINDING PROTEIN; PROTEIN NR4A3; RNA BINDING PROTEIN EWS; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHONDROSARCOMA; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRASKELETAL MYXOID CHONDROSARCOMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN TRANSPORT;

ADULT; AGED; CALMODULIN-BINDING PROTEINS; CHONDROSARCOMA; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 9; DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; EXTREMITIES; FEMALE; GENE REARRANGEMENT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; RNA-BINDING PROTEINS; SARCOMA; SOFT TISSUE NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 57749116119     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2008.114     Document Type: Article

References (24)

1. Lucas DR, Heim S. Extraskeletal myxoid chondrosarcoma. In: Fletcher CDM, Unni KK, Mertens F (eds). World Health Organization of Tumors. Pathology and Genetics of Tumours of Soft Tissue and Bone, 2002 edn. IARC Press: Lyon, France, 2002, pp 213-215.
2. Weiss SW, Goldblum JR. Cartilaginous soft tissue tumors. In: Enzinger & Weiss's Soft Tissue Tumors, 5th edn. Mosby Elsevier: St Louis, 2008, pp 1023-1031.
3. Meis-Kindblom JM, Bergh P, Gunterberg B, et al Extraskeletal myxoid chondrosarcoma: a reappraisal of its morphologic spectrum and prognostic factors based on 117 cases. Am J Surg Pathol 1999;23:636-650.
4. Kawaguchi S, Wada T, Nagoya S, et al Extraskeletal myxoid chondrosarcoma: a multi-institutional study of 42 cases in Japan. Cancer 2003;97:1285-1292.
5. Oliveira AM, Sebo TJ, McGrory JE, et al Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and ploidy analysis of 23 cases. Mod Pathol 2000;13:900-908.
6. McGrory JE, Rock MG, Nascimento AG, et al Extraskeletal myxoid chondrosarcoma. Clin Orthop Relat Res 2001;382:185-190.
7. Downs-Kelly E, Goldblum JR, Patel RM, et al The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms. Am J Surg Pathol 2008;32:8-13.
8. Hisaoka M, Hashimoto H. Extraskeletal myxoid chondrosarcoma: updated clinicopathological and molecular genetic characteristics. Pathol Int 2005;55:453-463.
9. Aigner T, Oliveira AM, Nascimento AG. Extraskeletal myxoid chondrosarcomas do not show a chondrocytic phenotype. Mod Pathol 2004;17:214-221.
10. Goh YW, Spagnolo DV, Platten M, et al Extraskeletal myxoid chondrosarcoma: a light microscopic, immunohistochemical, ultrastructural and immuno-ultrastructural study indicating neuroendocrine differentiation. Histopathology 2001;39:514-524.
11. Okamoto S, Hisaoka M, Ishida T, et al Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 18 cases. Hum Pathol 2001;32:1116-1124.
12. Panagopoulos I, Mertens F, Isaksson M, et al Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma. Genes Chromosomes Cancer 2002;35:340-352.
13. Sjogren H, Meis-Kindblom J, Kindblom LG, et al Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma. Cancer Res 1999;59:5064-5067.
14. Panagopoulos I, Mencinger M, Dietrich CU, et al Fusion of the RBP56 and CHN genes in extraskeletal myxoid chondrosarcomas with translocation t(9;17) (q22;q11). Oncogene 1999;18:7594-7598.
15. Sjogren H, Meis-Kindblom JM, Orndal C, et al Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma-cytogenetic, molecular genetic, and cDNA microarray analyses. Am J Pathol 2003;162:781-792.
16. Antonescu CR, Argani P, Erlandson RA, et al Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study. Cancer 1998;83:1504-1521.
17. Okamoto S, Hara K, Sumita S, et al Extraskeletal myxoid chondrosarcoma arising in the finger. Skeletal Radiol 2002;31:296-300.
18. Pfeifer JD. Tumors of soft tissue and bone. In: Molecular Genetic Testing in Surgical Pathology. Lippincott, Williams & Wilkins: Philadelphia, 2006, pp 186-231.
19. Sjogren H, Wedell B, Meis-Kindblom JM, et al Fusion of the NH2-terminal domain of the basic helix-loop-helix protein TCF12 to TEC in extraskeletal myxoid chondrosarcoma with translocation t(9;15)(q22;q21). Cancer Res 2000;60:6832-6835.
20. Hisaoka M, Ishida T, Imamura T, et al TFG is a novel fusion partner of NOR1 in extraskeletal myxoid chondrosarcoma. Genes Chromosomes Cancer 2004;40:325-328.
21. Hisaoka M, Okamoto S, Yokoyama K, et al Coexpression of NOR1 and SIX3 proteins in extraskeletal myxoid chondrosarcomas without detectable NR4A3 fusion genes. Cancer Genet Cytogenet 2004;152:101-107.
22. Brody RI, Ueda T, Hamelin A, et al Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma. Am J Pathol 1997;150:1049-1058.
23. Jakowski JD, Wakely Jr PE. Cytopathology of extraskeletal myxoid chondrosarcoma: report of 8 cases. Cancer 2007;111:298-305.
24. Lazar A, Abruzzo LV, Pollock RE, et al Molecular diagnosis of sarcomas: chromosomal translocations in sarcomas. Arch Pathol Lab Med 2006;130:1199-1207.